PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
EGF 27,487 Target Target ERBB3 1,154 251 0.04 -0.88 0.22 0.71
EPHA2 532 Target Target EPHB1 137 12 0.04 -0.94 0.09 0.78
CXCL16 341 Target Target CXCL9 1,016 26 0.04 -0.95 0.08 0.77
CD14 9,941 Target Target Toll-Like Receptor 2 2,174 204 0.04 -0.94 0.09 0.73
Platelet Aggregation 25,460 Disease Target Eptifibatide 772 194 0.04 -0.86 0.25 0.71
CXCL11 526 Target Target CXCL4/PF4 9 3 0.04 -0.81 0.33 0.76
CXCL11 526 Target Target CXCL3 145 12 0.04 -0.95 0.08 0.78
CD68 6,424 Target Target CD34 24,598 546 0.04 -0.95 0.08 0.72
Bivalirudin 891 Target Target Eptifibatide 772 36 0.04 -0.96 0.05 0.79
Arthritis 128,324 Disease Target Collagen 138,882 5,668 0.04 -0.96 0.04 0.68
CXCL9 1,016 Target Target CXCL2 750 37 0.04 -0.96 0.05 0.78
BAFFR 44 Target Target BLyS 457 6 0.04 -0.92 0.14 0.77
Tissue-Type Plasminogen Activator 5,020 Target Target D-Dimer 6,185 235 0.04 -0.96 0.05 0.75
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Bivalirudin 891 5 0.04 -0.83 0.31 0.75
CD4 112,219 Target Target CD14 9,941 1,398 0.04 -0.92 0.14 0.68
CCL19 658 Target Target CXCL9 1,016 34 0.04 -0.96 0.05 0.78
Alpha-Glucosidase 4,319 Target Target Pancreatic Alpha-Amylase 423 56 0.04 -0.93 0.13 0.74
4-1BB Receptor 20 Target Target CD137 474 4 0.04 -0.89 0.20 0.76
Cancer 1,053,491 Disease Target Erbb2 4,536 2,833 0.04 -0.61 0.62 0.63
Diabetic Nephropathy 12,496 Disease Target Renin 43,456 953 0.04 -0.95 0.08 0.70
CCL5 2,002 Target Target CXCL3 145 22 0.04 -0.92 0.15 0.75
Kappa-Type Opioid Receptor 4 Target Target Sphingosine 1-Phosphate Receptor 1 150 1 0.04 -0.86 0.25 0.77
C5a 4,164 Target Target Platelet Activating Factor 9,915 259 0.04 -0.96 0.06 0.73
ERBB4 994 Target Target EGF 27,487 210 0.04 -0.88 0.21 0.70
CXCL10 2,386 Target Target CCL1 220 29 0.04 -0.93 0.13 0.75
BMP-2B 18 Target Target BMP-4 1,255 6 0.04 -0.81 0.33 0.74
Analgesia 44,857 Disease Target Mu Opioid Receptor 4,576 567 0.04 -0.93 0.12 0.70
ERK1 18,374 Target Target EGF 27,487 878 0.04 -0.96 0.05 0.71
CD1A 2,739 Target Target CD34 24,598 317 0.04 -0.93 0.12 0.71
Aurora B kinase 415 Target Target Aurora A kinase 318 14 0.04 -0.96 0.04 0.79
Epidermal Growth Factor Receptor 24,772 Target Target ERBB4 994 191 0.04 -0.90 0.19 0.70
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
CCL3 1,427 Target Target CXCL11 526 33 0.04 -0.96 0.06 0.76
CCL18 256 Target Target CCL1 220 9 0.04 -0.96 0.04 0.80
CCL19 658 Target Target CXCL10 2,386 47 0.04 -0.95 0.07 0.75
EPHB4 329 Target Target EPHA3 140 8 0.04 -0.96 0.06 0.78
Neutral Alpha-Glucosidase C 6 Target Target Alpha-Glucosidase 4,319 6 0.04 -0.38 1.00 0.72
CCL19 658 Target Target CCL3 1,427 36 0.04 -0.96 0.05 0.76
CXCL10 2,386 Target Target CCL21 808 51 0.04 -0.96 0.06 0.75
CD4 112,219 Target Target CD154 1,512 477 0.04 -0.83 0.32 0.67
EPHA3 140 Target Target EPHB1 137 5 0.04 -0.96 0.04 0.80
Diabetes 332,602 Disease Target Angiotensin Converting Enzyme 31,674 3,701 0.04 -0.93 0.12 0.64
CXCL7 76 Target Target CCL5 2,002 14 0.04 -0.90 0.18 0.74
Tubulin Beta-1 Chain 3 Target Target Inosine-5'-Monophosphate Dehydrogenase 261 1 0.04 -0.81 0.33 0.76
Angiotensin Converting Enzyme 31,674 Target Target Aldosterone Receptor 528 146 0.04 -0.85 0.28 0.69
CXCL16 341 Target Target CXCL11 526 15 0.04 -0.96 0.04 0.78
EPHA2 532 Target Target EPHB2 385 16 0.04 -0.96 0.04 0.78
CXCL9 1,016 Target Target CCL21 808 32 0.04 -0.96 0.04 0.77
CCL2 3,560 Target Target CXCL11 526 48 0.04 -0.95 0.09 0.74
CCL19 658 Target Target CCL2 3,560 53 0.03 -0.95 0.08 0.74
CER 2,421 Target Target Sphingomyelinase 3,060 93 0.03 -0.97 0.04 0.75
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
Tissue-Type Plasminogen Activator 5,020 Target Target Antithrombin 13,773 282 0.03 -0.96 0.06 0.72
Hyperbilirubinemia 5,757 Disease Target Udp-Glucuronosyltransferase 2,219 121 0.03 -0.96 0.05 0.74
APOA1 958 Target Target APOE 12,771 118 0.03 -0.93 0.12 0.71
Collagen 138,882 Target Target BMP-2 3,889 783 0.03 -0.89 0.20 0.66
CCL14 34 Target Target Eotaxin-3/CCL26 26 1 0.03 -0.97 0.04 0.81
Draflazine 33 Drug Target Ent2 108 2 0.03 -0.96 0.06 0.79
CXCL11 526 Target Target CXCL2 750 21 0.03 -0.97 0.04 0.77
Cancer 1,053,491 Disease Target Cox-2 21,583 5,031 0.03 -0.87 0.23 0.61
Graft Versus Host Disease 15,741 Disease Target CD4 112,219 1,399 0.03 -0.95 0.09 0.67
CAMK2D 21 Target Target CAMK4 43 1 0.03 -0.96 0.05 0.80
CCL4 5,638 Target Target CXCL2 750 68 0.03 -0.95 0.09 0.73
CCL5 2,002 Target Target CCL21 808 42 0.03 -0.96 0.05 0.75
Androgen Receptor 12,918 Target Target Estrogen Receptor Beta 1,924 163 0.03 -0.95 0.08 0.71
CXCL11 526 Target Target CCL1 220 11 0.03 -0.96 0.05 0.77
CCL19 658 Target Target CXCL11 526 19 0.03 -0.97 0.04 0.77
Metastatic Breast Cancer 9,288 Disease Target CA 15-3 898 93 0.03 -0.94 0.10 0.72
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
CCL4 5,638 Target Target CXCL9 1,016 76 0.03 -0.96 0.07 0.73
Rheumatoid Arthritis 78,952 Disease Target Collagen 138,882 3,319 0.03 -0.97 0.04 0.66
CD4 112,219 Target Target CD95 4,266 691 0.03 -0.91 0.16 0.66
Thrombocytopenia 35,805 Disease Target Bivalirudin 891 178 0.03 -0.89 0.20 0.69
Neck Pain 5,675 Disease Target C7 7,027 199 0.03 -0.97 0.04 0.73
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
CCL18 256 Target Target CCL2 3,560 30 0.03 -0.94 0.12 0.73
CD1A 2,739 Target Target CD4 112,219 547 0.03 -0.89 0.20 0.66
CXCL16 341 Target Target CXCL7 76 5 0.03 -0.96 0.07 0.77
Albuminuria 6,831 Disease Target Renin 43,456 535 0.03 -0.95 0.08 0.69
Epidermal Growth Factor Receptor 24,772 Target Target ERK1 18,374 662 0.03 -0.97 0.04 0.70
Cancer 1,053,491 Disease Target EGF 27,487 5,238 0.03 -0.90 0.19 0.61
Aldosterone Receptor 528 Target Target Renin 43,456 147 0.03 -0.85 0.28 0.68
CXCL3 145 Target Target CXCL10 2,386 18 0.03 -0.93 0.12 0.73
CCL4 5,638 Target Target CCL1 220 34 0.03 -0.92 0.15 0.72
Endostatin 1,599 Target Target Angiostatin K1-3 17 5 0.03 -0.84 0.29 0.73
CXCL16 341 Target Target CCL5 2,002 25 0.03 -0.96 0.07 0.74
CCL7 274 Target Target CCL18 256 8 0.03 -0.97 0.03 0.78
CD68 6,424 Target Target CD4 112,219 808 0.03 -0.93 0.13 0.66
CCL18 256 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
Epidermal Growth Factor Receptor 24,772 Target Target Epiregulin 291 80 0.03 -0.85 0.27 0.69
Deep Vein Thrombosis 10,952 Disease Target Antithrombin 13,773 365 0.03 -0.97 0.03 0.72
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
Alpha-Amylase 7,171 Target Target AMY1A 13 9 0.03 -0.55 0.69 0.70
Graft Versus Host Disease 15,741 Disease Target CD34 24,598 573 0.03 -0.97 0.04 0.70
CCL7 274 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
Thromboembolic Disease 3,336 Disease Target Antithrombin 13,773 196 0.03 -0.96 0.06 0.71
CXCL7 76 Target Target CCL2 3,560 15 0.03 -0.89 0.20 0.72
Calmodulin 25,240 Target Target CAMK4 43 30 0.03 -0.55 0.70 0.69
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79